Chemical Properties
light yellow to purple or light brown powder or
Uses
2,3-Diamino-5-bromopyridine may be used in the preparation of the following heterocyclic compounds:
- 6-bromoimidazo-[b]pyridine
- 11-bromopyrido[2′,3′:5,6]pyrazino[2,3-f][1,10]phenanthroline
- 6-bromo-3-(tetrahydro-2H-pyran-2-yl)-3H-imidazo[4,5-b]pyridine
General Description
2,3-Diamino-5-bromopyridine can be prepared from 2-amino-3-nitro-5-bromopyridine via reduction using stannous chloride.
Synthesis
The general procedure for the synthesis of 2,3-diamino-5-bromopyridine from 2-amino-3-nitro-5-bromopyridine is as follows:
Part I: Synthesis of imidazo[4,5-b]pyridin-2(3H)-one boronic acid
Step 1: Preparation of 5-bromopyridine-2,3-diamine
5-Bromo-3-nitropyridin-2-amine (3 g) was dissolved in a solvent mixture of isopropanol (56 mL) and water (28 mL). Ammonium chloride (1.47 g, 2 eq.) and iron powder (2.31 g, 3 eq.) were subsequently added. The reaction mixture was heated to 90°C and kept at this temperature for 45 minutes. Upon completion of the reaction, the mixture was cooled, diluted with ethyl acetate (EtOAc), filtered to remove insoluble matter, and the organic and aqueous layers were separated. The organic layer was subsequently washed with saturated brine, dried over anhydrous sodium sulfate and concentrated under reduced pressure to afford the target product 2,3-diamino-5-bromopyridine as a solid (2.45 g, 95% yield).
Product characterization data: 1H-NMR (300 MHz, DMSO-d6) δ 7.25 (d, 1H), 6.77 (d, 1H), 5.70-5.40 (bs, 2H), 5.20-4.80 (bs, 2H).
References
[1] Journal of Medicinal Chemistry, 1995, vol. 38, # 18, p. 3524 - 3535
[2] Journal of Medicinal Chemistry, 1997, vol. 40, # 22, p. 3679 - 3686
[3] Patent: WO2010/121164, 2010, A2. Location in patent: Page/Page column 60
[4] Patent: EP1460067, 2004, A1. Location in patent: Page 29
[5] Journal of Medicinal Chemistry, 2013, vol. 56, # 3, p. 1160 - 1170